Specialty
Obstetrics & Gynecology devices
Last checked: Nov 19, 2026Source: openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
997
510(k), De Novo and PMA
Decisions, last 36 months
283
Recruiting device trials
125
Industry sponsored
Adverse event reports
11,550
Received Nov 1, 2025 to Nov 19, 2026
Latest FDA decisions
The 8 newest. A specialty is the FDA review panel, or a list of product codes for a narrower view.
- Pleiades Device510(k)
My123Baby Medical Limited Dba Boost Fertility
K262066 · Decided Oct 30, 2026 · 130 days after receipt
Device type: Labware, Assisted Reproduction (MQK) · Obstetrics & Gynecology
K262125 · Decided Oct 29, 2026 · 127 days after receipt
Device type: Pump, Breast, Powered (HGX) · Obstetrics & Gynecology
K262570 · Decided Oct 29, 2026 · 97 days after receipt
Device type: Catheter, Balloon, Dilation Of Cervical Canal Prior To Labor (PFJ) · Obstetrics & Gynecology
- Cyperus510(k)
K262276 · Decided Oct 26, 2026 · 112 days after receipt
Device type: Labware, Assisted Reproduction (MQK) · Obstetrics & Gynecology
K261782 · Decided Oct 16, 2026 · 140 days after receipt
Device type: Pump, Breast, Powered (HGX) · Obstetrics & Gynecology
K261234 · Decided Oct 9, 2026 · 177 days after receipt
Device type: Microtools, Assisted Reproduction (Pipettes) (MQH) · Obstetrics & Gynecology
K262090 · Decided Oct 9, 2026 · 109 days after receipt
Device type: Labware, Assisted Reproduction (MQK) · Obstetrics & Gynecology
P250051 · Decided Sep 28, 2026 · 292 days after receipt
Device type: Barrier, absorbable, adhesion (MCN) · Obstetrics & Gynecology
FDA decisions per month
Last 36 months, by decision date and pathway.
- 510(k)
- De Novo
- PMA
View as table
| Month | 510(k) | De Novo | PMA |
|---|---|---|---|
| Dec 23 | 11 | 0 | 0 |
| Jan 24 | 5 | 0 | 0 |
| Feb 24 | 4 | 0 | 0 |
| Mar 24 | 9 | 0 | 0 |
| Apr 24 | 4 | 0 | 0 |
| May 24 | 11 | 0 | 0 |
| Jun 24 | 10 | 0 | 0 |
| Jul 24 | 8 | 0 | 0 |
| Aug 24 | 11 | 0 | 0 |
| Sep 24 | 8 | 0 | 0 |
| Oct 24 | 4 | 0 | 0 |
| Nov 24 | 3 | 0 | 0 |
| Dec 24 | 7 | 0 | 0 |
| Jan 25 | 7 | 0 | 0 |
| Feb 25 | 8 | 0 | 0 |
| Mar 25 | 6 | 0 | 0 |
| Apr 25 | 13 | 0 | 0 |
| May 25 | 8 | 0 | 0 |
| Jun 25 | 4 | 0 | 0 |
| Jul 25 | 6 | 0 | 0 |
| Aug 25 | 12 | 0 | 0 |
| Sep 25 | 9 | 0 | 1 |
| Oct 25 | 8 | 0 | 0 |
| Nov 25 | 3 | 0 | 0 |
| Dec 25 | 9 | 0 | 0 |
| Jan 26 | 3 | 0 | 0 |
| Feb 26 | 9 | 0 | 0 |
| Mar 26 | 8 | 0 | 0 |
| Apr 26 | 14 | 0 | 0 |
| May 26 | 9 | 0 | 0 |
| Jun 26 | 15 | 0 | 0 |
| Jul 26 | 7 | 1 | 0 |
| Aug 26 | 8 | 0 | 0 |
| Sep 26 | 12 | 0 | 1 |
| Oct 26 | 7 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 |
Recruiting device trials
Industry-sponsored device trials that are recruiting now, most recently updated first.
Diality Inc.Not on our public-company list
NCT06613568 · 50 participants (planned) · Start Oct 6, 2025 · Primary completion Mar 2027
Device: Moda-flx Hemodialysis System™ · For: End Stage Kidney Disease
Sites: San Dimas, California; New Hyde Park, New York; Knoxville, Tennessee · 6 sites in all
Next Life SciencesNot on our public-company list
NCT07361120 · 40 participants (planned) · Start Jan 15, 2026 · Primary completion Dec 2026
Device: Occlusion System · For: Fertility; Fertility, Male; Healthy Male Adults
Sites: Maribyrnong, Australia; St Kilda, Australia; Vancouver, Canada · 4 sites in all
Aqua Therapeutics, Inc.Not on our public-company list
NCT07925008 · 15 participants (planned) · Start Jul 30, 2026 · Primary completion Dec 30, 2027
Device: Aqua Therapeutics Thermal Therapy Vapor Ablation System (ATTTVAS) · For: Menorrhagia
Sites: Feldkirch, Austria; Roma, Italy
Relief srlNot on our public-company list
NCT07327528 · 30 participants (planned) · Start Jul 9, 2025 · Primary completion Jun 30, 2027
Device: UroRelief, a sterile, single-use, endourethral medical device suitable for both men and women, which is positioned at the bladder neck for the treatment of stress incontinence. · For: Urinary Incontinence , Stress
Sites: Milan, Italy; Siena, Italy; Terni, Italy
- Akyva First In HumanRecruiting
Iota Biosciences, IncNot on our public-company list
NCT06956209 · 15 participants (planned) · Start Sep 24, 2025 · Primary completion Sep 2028
Device: Direct Bladder Wall Stimulation · For: Underactive Bladder
Sites: Woolloongabba, Australia; Adelaide, Australia; Melbourne N., Australia
Axonics, Inc.Not on our public-company list
NCT07335484 · 75 participants (planned) · Start Apr 30, 2026 · Primary completion Nov 2026
Device: Axonics External Trial System (ETS) · For: Urinary Urge Incontinence (UUI); Urinary Frequency (UF); Fecal Incontinence (FI) and 1 more
Sites: Birmingham, Alabama; Macon, Georgia; Chicago, Illinois · 6 sites in all
How new technology gets paid for
Recent Medicare coverage decisions that touch this specialty.
Reports received
11,550
Received Nov 1, 2025 to Nov 19, 2026. Includes 63 of another or unstated type.
Malfunction reports
10,274
89% of reports
Injury reports
1,199
10% of reports
Death reports
14
0.1% of reports
Adverse event reports received per month
By the date FDA received each report. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Nov 25 | 805 | 112 | 0 | 0 |
| Dec 25 | 996 | 104 | 3 | 2 |
| Jan 26 | 722 | 68 | 1 | 0 |
| Feb 26 | 772 | 102 | 2 | 0 |
| Mar 26 | 1,292 | 103 | 2 | 0 |
| Apr 26 | 981 | 103 | 0 | 0 |
| May 26 | 811 | 110 | 0 | 0 |
| Jun 26 | 696 | 84 | 1 | 0 |
| Jul 26 | 719 | 78 | 0 | 8 |
| Aug 26 | 858 | 127 | 1 | 18 |
| Sep 26 | 976 | 94 | 0 | 21 |
| Oct 26 | 646 | 114 | 4 | 14 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types with the most reports
Widely used device types get more reports. This is not a ranking of safety.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.